Novo Nordisk Warns of First Sales Drop Since Start of Ozempic

New York Times - Feb 4, 2026

The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry, especially Eli Lilly, which gave a much rosier outlook to investors.

Read full article

More News

Recommended